Sangart, Inc. is a biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents.

Hemospan® is a human hemoglobin-based product designed to serve as an oxygen transport agent for a variety of therapeutic uses.

Sangart’s products are based upon extensive research into the factors that govern oxygen delivery by cell-free hemoglobin.